In light of their position paper on ‘stroke prevention in the longevity era’ published recently in Stroke, Gustavo Saposnik ...
Following his recent induction into the Canadian Medical Hall of Fame—and at the end of his term as Canadian Neurological ...
Brainomix and Remedy Pharmaceuticals have announced “promising new findings” from a post-hoc analysis of the Phase 3 CHARM ...
Pharaoh Neuro has announced that the US Food and Drug Administration has granted Breakthrough Device designation to its ...
As the topic of radiation safety across various interventional specialties continues to garner increased interest, Melissa ...
The UK government has confirmed that it will continue to accept CE marked medical devices on a long-term basis, meaning ...
On World Stroke Day 2026 (29 October), the European Society of Minimally Invasive Neurological Therapy (ESMINT) has called for sustained investment in education, research, and stroke services.
Late-breaking research presented at the 2026 World Stroke Congress (WSC; 21–23 October, Seoul, South Korea) has provided fresh insights on the benefits of individualised strategies for ...
In light of their position paper on ‘stroke prevention in the longevity era’ published recently in Stroke, Gustavo Saposnik (Toronto, Canada) and Conrado E... Following his recent induction into the ...
Route 92 Medical has announced the publication of initial results from the SUMMIT NZ clinical trial—a single-arm, multicentre, prospective trial evaluating its proprietary Monopoint operating platform ...
Flow Neuroscience, the creator of what is currently Europe’s only medically approved transcranial direct current stimulation (tDCS) device and behavioural therapy app for depression, has closed a US$9 ...
InspireMD has been granted premarket approval (PMA) from the US Food and Drug Administration (FDA) for its CGuard Prime carotid stent system in the USA—news that follows the company’s recent ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results